Mbx Biosciences, Inc. · NASDAQ:MBX

Orbimed Advisors LLC reported a 7.70% stake in Mbx Biosciences, Inc. (Schedule 13D/A)

Event Feb 5, 2026 · Filed Feb 11, 2026

Orbimed Advisors LLC reported a 7.70% stake in Mbx Biosciences, Inc., 3,637,887 shares, with active intent on Feb 5, 2026. Filed Feb 11, 2026 (Schedule 13D/A).

Stake
7.70%
Shares
3,637,887
Intent
Active
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC7.70%3,637,887
ORBIMED CAPITAL GP VII LLC6.30%2,958,000
OrbiMed Genesis GP LLC1.40%679,887

Source

View original at SEC

Related